Le cout du diabete de type 2: resume de l'enquete europeenne CODE-2 et analyse de la situation en Belgique.

Belgium; Diabetes Complications/economics; Diabetes Mellitus, Type 2/economics; Europe; Health Care Costs/statistics & numerical data; Health Expenditures/statistics & numerical data; Humans

Abstract :

[en] Type 2 diabetes mellitus is a common chronic disease whose economic impact on both patients and society is constantly increasing. "The Cost of Diabetes in Europe--Type 2 study" is the first coordinated attempt to measure total healthcare costs of type 2 diabetes mellitus in Europe. On average, 3% of the population with type 2 diabetes accounted for 5% of the total healthcare expenditure. Complications have a substantial impact on the costs of managing type 2 diabetes. The prevention of complications, especially cardiovascular disease, will potentially reduce overall healthcare expenditure.

Disciplines :

Endocrinology, metabolism & nutrition

Author, co-author :

Wallemacq, Caroline ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques

Van Gaal, L. F.

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale

Language :

French

Title :

Le cout du diabete de type 2: resume de l'enquete europeenne CODE-2 et analyse de la situation en Belgique.

Alternative titles :

[en] The cost of type 2 diabetes: summary of the Cost of Diabetes in Europe-Type II study (CODE-2) and analysis of the situation in Belgium

Publication date :

2005

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Special issue title :

Le diabète sucré dans tous ses états

Volume :

Issue :

5-6

Pages :

278-84

Peer reviewed :

Peer reviewed

Additional URL :

http://www.rmlg.ulg.ac.be

Available on ORBi :

since 07 April 2009

Statistics

Number of views

2111 (9 by ULiège)

Number of downloads

2763 (14 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Massi-Benedetti M.- The Cost of Diabetes Type II in Europe: The CODE-2 Study. Diabetologia, 2002, 45, S1-S4.
Lefèbvre PJ.- Le diabète hier, aujourd'hui et demain. L'action de la Fédération Internationale du Diabète. Rev Med Liège, 2005, 60, 273-277.
Scheen AJ, Paquot N.- Le diabète de type 2: approches diagnostiques, objectifs glycémiques et stratégies thérapeutiques. Rev Med Liège, 1999, 54, 659-666.
Brandle M, Zhou H, Smith BRK, et al.- The direct medical cost of type 2 diabetes. Diabetes Care, 2003, 26, 2300-2304.
American Diabetes Association.- Economic costs of diabetes in the U.S. in 2002. Diabetes Care, 2003, 26, 917-932.
Scheen AJ, Lefèbvre PJ.- Pharmaco-économie du diabète de type 2. Rev Med Liège, 1998, 53, 285-289.
Scheen AJ, Van Gaal LF, Annemans L.- Gezondheid-seconomische aspecten van type-2-diabetes. Tijdschr Geneeskunde, 1999, 55, 24, 1753-1759.
Jönsson B.- Revealing the cost of type II diabetes in Europe. Diabetologia, 2002, 45, S5-S12.
Williams R, Van Gaal L, Lucioni C.- Assessing the impact of complications on the costs of Type II diabetes. Díabetologia, 2002, 45, S13-S17.
Haffner SM, Lehto S, Ronnemaa T, et al.- Mortality from coronary heart disease in subjects with Type 2 diabetes and in non-diabetic subjects with and without myocardial infarction. N Engl J Med, 1998, 399, 2329-2348.
Teutsch S.- The cost-effectiveness of preventing diabetes. Diabetes Care, 2003, 26, 2693-2694.
Liebl A, Mata M, Eschwège E.- Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia, 2002, 45, S23-S28.
The CDC Diabetes Cost-effectiveness Group.- Cost-effectiveness of intensive glycemic control, intensified hypertension control and serum cholesterol level reduction for type 2 diabetes. JAMA, 2002, 287, 2542-2551.
Scheen AJ, Van Gaal LF.- Le diabète de type 2 au coeur du syndrome métabolique: plaidoyer pour une prise en charge globale. Rev Med Liège, 2005, 60, 566-571.
Institut Belge de l'Economie de la Santé.- Aspects médico-économiques d'interventions dans le cadre de la prévention et du traitement du diabète en Belgique. IBES Briefing, 2001, N° 32.

Similar publications

Sorry the service is unavailable at the moment. Please try again later.